Advocacy Panel Discussion

World Asthma Day 2023

The European Respiratory Society (ERS) and the Global Initiative for Asthma (GINA) will discuss GINA 2023 report on the day of its release, and will discuss the ERS and GINA perspectives on asthma and the environment, looking to a healthier future.

2 May, 2023 | Online

17:00–18:00 CEST

Moderators:
Prof. Arzu Yorgancıoğlu; Prof. Nicolas Roche
Speakers: Helen Reddel; Zorana J. Andersen; Kjeld Hansen; Fríða Rún Þórðardóttir

Fees: Free for ERS members and non-members
Find out more about becoming a member

For World Asthma Day 2023, the European Respiratory Society (ERS) and the Global Initiative for Asthma (GINA) will join forces to discuss key updates to recommendations about asthma management for adults, adolescents and children in the GINA 2023 strategy report, on the day of its release.

Asthma is a complex disease caused by a mix of genetic and environmental factors which still to this day is the most common chronic disease in children and adolescents globally and one of the most common chronic diseases in adults. Recognized by the World Health Organization (WHO) as both cause and effect of poverty in low- and middle-income countries, it is estimated to affect 339 milion people worldwide.

The webinar will also include discussion about how climate change and air pollution can affect asthma patients, and what clinicians can do to select the most appropriate inhaler for their patients. In light of the new Air Quality Directive proposed by the European Commission, this event will provide an outlook on what is needed to guarantee a healthier future for patients at national, European and global level.

The webinar format will be as follows:

  • Welcome remarks and Introduction: Arzu Yorgancıoğlu, ERS Advocacy Council Chair and Chair of GINA; Nicolas Roche, ERS Science Council Chair (10 min)
  • Global Initiative for Asthma Strategy report: 2023 update (including environmental issues): Helen Reddel, Chair of GINA Science Committee (20 min)
  • Asthma and the environment, an ERS perspective: Zorana J. Andersen, ERS Environment and Health Committee Chair (10 min)
  • The patient perspective: Kjeld Hansen, Chair of European Lung Foundation (5 min)
  • European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) representative: Ms. Fríða Rún Þórðardóttir, Secretary of EFA (5 min)
  • Q&A and closing remarks (10 min)

For more information or questions, please email Marta Montanari at ERS.

Mediators

Prof. Arzu Yorgancıoğlu  - profile image
Prof. Arzu Yorgancıoğlu
ERS Advocacy Council Chair and Professor of Respiratory Medicine; Chair of GINA Board of Directors

Prof. Nicolas Roche - profile image
Prof. Nicolas Roche
Current ERS Science Council Chair and former ERS Guidelines Director

Speakers

Prof. Helen Reddel - profile image
Prof. Helen Reddel
Chair of the Science Committee of the Global Initiative for Asthma (GINA)

Helen Reddel is a Research Leader at the Woolcock Institute of Medical Research, Chair of the GINA Science Committee.


Kjeld Hansen - profile image
Kjeld Hansen
Chair of the European Lung Foundation (ELF)

Kjeld Hansen is the Chair of the European Lung Foundation (ELF) and has been associated with ELF since 2012. In his professional capacity, Kjeld is working with digitalisation and is employed by the academic institution Kristiania in Oslo, Norway.

In his patient advocacy work, Kjeld is inspired by digitalisation as an enabler for new approaches and organisational forms that put people with respiratory conditions at the centre of the initiative.


Declaration of Interests

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

None

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Prof. Zorana J. Andersen - profile image
Prof. Zorana J. Andersen
Chair of the ERS Environment and Health Committee

Friða Rún Þórðardóttir - profile image
Friða Rún Þórðardóttir
Dietitian; Chair of the Asthma and Allergie Association of Iceland (AO); board member of the European Federation of Allergy and Airways Diseases Patients' Associations (EFA)